RheumNow ACR Week in Review: ACR Wrap-Up (10.26.18) Save

This past week in Chicago gave us a plethora of new and eye-opening research, people, KOLs, exhibits, sessions, guidelines, posters and a never-ending supply of coffee served in small paper cups.  ACR 2018 highlights for me included:

ACR8.RheumNow.com – featuring over 1000 new content pieces – tweets, videos, panel discussions, convention and Chicago pics, quotes from notable teachers. Find your info, your way – navigate by header boxes (for RA, PsA, AS, Gout, OP), click on reports by Day (D1, D2, etc), click on category buttons (RA, PsA, gout, etc) or on the video, news buttons or use the seach field.  My favorites about this site include the RheumNow Roundtable panel discussions (especially the PsA, Gout and Spondylitis Panels), Videos by Dr. Dao on Great Debate, Dr. Tate on Exhibitor smack-down, Dr. Sam Whittle on SCOT trial and Dr. David Liew on irAE with Checkpoint inhibitors.  Lastly checkout the talking head audio commentaries found on the RA, PsA, AS, Gout and OP pages of the websites – 30 second morsels of expert commentary related to an abstract our Topic Editors found interesting. Click HERE to go to the ACR18 website

• Abstract L20 - Tanezumab in OA 
• Updates on Jaks  
• Abstract 2815 - Baricitinib long term data on CV events and VTE
• Abstract 1518 - Obesity effects with Jak inhibitors
• Abstract L09 - Comparative Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors
• New Jaks
• #891 - Upadacitinib (UPA) In the SELECT–EARLY study
• # 886 - Switching from ADA to Baricitinib
• #1821 - Filgotinib in Psoriatic Arthritis
• Old (Approved) Drugs and their new indications
• Abstract 2785 - Ustekinumab in SLE: week 54 data
• Abstract 1791 - Apremilast in Behcets – new phase 3 trial
• Abstract 970 - Baricitinib in SLE
• Abstract 898 - Tocilizumab in Systemic Sclerosis
• Abstract 837 - High Dose Influenza vaccination in RA patients
• Abstract 1286 – Methotrexate prophylaxis with IV pegloticase for refractory gout
• Reproductive health draft guidelines
• AS/SpA SPARTAN Guidelines in Draft form
• Large-Vessel Vasculitis Classification: Draft Criteria Presented at ACR/ARHP 2018
• Abstract 1864- Ixekizumab in Axial Spondyloarthritis  - The COAST-V trial
• Abstract L13 - 5 year data on secukinumab in AS
• Abstract 651 - MRI Reading of SI joints by Rheumatologists and Radiologists